Skip Navigation

Cardiovascular Research 2004 61(2):307-316; doi:10.1016/j.cardiores.2003.11.025
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Grohé, C.
Right arrow Articles by Schlüter, K.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grohé, C.
Right arrow Articles by Schlüter, K.-D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide*

Christian Grohéa, Martin van Eickelsa, Sibylle Wenzelb, Rainer Meyerc, Heike Degenhardtd, Pieter A Doevendansd, Marcus P Heinemannb, Günter Rossb and Klaus-Dieter Schlüterb,*

aMedizinische Universitäts-Poliklinik, Bonn, Germany
bPhysiologisches Institut, Justus-Liebig-Universität Giessen, Aulweg 129, D-35392 Giessen, Germany
cPhysiologisches Institut II, Universität, Bonn, Germany
dDepartment of Cardiology, Heart-Lung Centrum, Utrecht, Netherlands

* Corresponding author. Tel.: +49-641-99-47-212; fax: +49-641-99-47-239. klaus-dieter.schlueter{at}physiologie.med.uni-giessen.de

Objective: Parathyroid hormone-related peptide (PTHrP) expression is modulated by estrogen. It is expressed in coronary endothelial cells and involved in the endothelium-dependent regulation of coronary resistance and cardiac function. In the present study, we hypothesized that endogenously synthesized and released PTHrP contributes to sex-specific differences in the regulation of cardiac function. Methods: The influence of sex on ventricular PTHrP expression in normotensive rats was determined via real-time PCR and immunoblot analysis. Sex-specific effects of exogenous PTHrP or endogenous released PTHrP were determined in vitro on isolated ventricular cardiomyocytes, Langendorff preparations on isolated hearts and in vivo using different agonistic or antagonistic PTHrP peptides. Results: Ventricular expression of PTHrP was elevated in hearts from female rats compared to male counterparts. Addition of PTHrP(1–36) did not increase left ventricular function in hearts from either sex, but increased coronary flow in hearts from female rats significantly greater than in those from males. 5Ile-PTHrP(1–36), which was used to antagonize endogenously released PTHrP, reduced left ventricular function in females but not males in vitro and in vivo. Under conditions of increased endogenous PTHrP release, i.e. ischemia–reperfusion, antagonization of PTHrP significantly reduced post-ischemic recovery in hearts from females but not in those from males. Conclusions: Sex determines the ventricular expression of PTHrP mRNA and protein. The results indicate that PTHrP may improve cardiac function to a greater extent in women than in men following a brief period of ischemia.

KEYWORDS Endothelium-derived factors; Sex; Vasculature; Ventricle; Regional blood flow


Time for primary review 00 days

* Gerd Heusch, University of Essen, served as Guest Editor for this article.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
v. E. Martin, S. Rolf, P. A. Doevendans, R. Meyer, C. Grohe, and K.-D. Schluter
The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats
Eur J Heart Fail, December 1, 2005; 7(7): 1079 - 1084.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.